Radiopharm Theranostics
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
62 Lygon St L 3, Carlton South, Victoria...Phone Number
+61 398245254Revenue
<$5 MillionStock Symbol
RADIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Radiopharm Theranostics
Radiopharm Theranostics, founded in 2021, is a research and development company focused on creating radiopharmaceutical products for both diagnostic and therapeutic applications. The company specializes in developing innovative solutions for areas with significant unmet medical needs, combining radioactive compounds with targeting molecules to diagnose and treat diseases. Radiopharm Theranostics operates in multiple locations and maintains a strong focus on technological advancement in the medical and healthcare sectors.Explore more
Radiopharm Theranostics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Radiopharm Theranostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Radiopharm Theranostics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Radiopharm Theranostics has new funding data
Radiopharm Theranostics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Radiopharm Theranostics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Radiopharm Theranostics is spiking on competitors!
Product Launch: Get notified when Radiopharm Theranostics launches new products
Click to see if Radiopharm Theranostics had a recent Job posting/layoffs
Earning: See what the market has to say on Radiopharm Theranostics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Radiopharm Theranostics
Compare insights from companies similar to Radiopharm Theranostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Radiopharm Theranostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Radiopharm Theranostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Radiopharm Theranostics.
Radiopharm Theranostics financials insights
Gather financial insights about Radiopharm Theranostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Private Equity
$70M
Radiopharm Theranostics Tech Stack
A closer look at the technologies used by Radiopharm Theranostics
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Radiopharm Theranostics News & Media
Regal-backed biotech Radiopharm Theranostics seeks $16m - AFR
The $67 million ASX-listed company had lead manager and bookrunner Bell Potter offering new shares at 1.5¢ on Wednesday.Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
First RECIST-confirmed durable Partial Response at current highest dose level #3 (90mCi) with the patient remaining progression free beyond seven monthsRadiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint.Radiopharm Theranostics (ASX:RAD) Announces Finance and Governance Leadership Changes
Radiopharm Theranostics (ASX:RAD) Announces Finance and Governance Leadership Changes
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Radiopharm Theranostics
Sign Up For FreeTo access detailed company insights
Radiopharm Theranostics, founded in 2021, is a research and development company focused on creating radiopharmaceutical products for both diagnostic and therapeutic applications. The company specializes in developing innovative solutions for areas with significant unmet medical needs, combining radioactive compounds with targeting molecules to diag... Read More
